1. Mr. Parameswar Patra
Ph.D. Student (ICMR SRF Fellow)
Research Area: Nanotechnology based approaches for Leukemia Therapy
M. Pharm.: Roland Institute of Pharmaceutical Sciences, Berhampur, Orissa, India
Publications (TPRL Group):
- Akash Chaurasiya, Parameswar Patra, Pranathi Thathireddy, Amruta Gorajiya. “PLGA-based Micro- and Nano-particles: From Lab to Market”. In Micro- and Nanotechnologies-Based Product Development, CRC-Taylor & Francis. pp 83-95, 2021.
https://www.taylorfrancis.com/chapters/edit/10.1201/9781003043164-6/plga-based-micro-nano-particles-akash-chaurasiya-parameswar-patra-pranathi-thathireddy-amruta-gorajiya?context=ubx&refId=02cf4fa7-fa8f-45a1-be57-77ed7789533e
https://doi.org/10.1201/9781003043164 - Ridahunlang Nongkhlaw, Parameswar Patra, Akash Chaurasiya, Nirmal Jayabalan, Sachin Dube, “Biologics: Delivery options and formulation strategies”. In Drug Delivery Aspects, Volume 4: Expectations and Realities of Multifunctional Drug Delivery Systems, Elsevier. pp 115-155, 2020. https://doi.org/10.1016/B978-0-12-821222-6.00006-3
- Akash Chaurasiya, Parameswar Patra, Chiranjeev Singh and Manika Chourasiya, "Potential of nanotechnology based approaches for HIV/AIDS treatment", ISSRF Newsletter, Indian Society for the Study of Reproduction and Fertility, 26, 63-66 (2020).
2. Mr. Sumeet Katke
Ph.D. Student (PDA Sponsored Project)
Research Area: Investigation of liposomal carrier system for anticancer drug delivery
M. Pharm.: BITS Pilani - Hyderabad Campus
Publications (TPRL Group):
- Tanisha Gupta, Rakesh Kumar Sahoo, Himani Singh, Sumeet Katke, Akash Chaurasiya, Umesh Gupta, "Lipid Based Nanocarriers in the Treatment of Glioblastoma (GBM): Challenges and Opportunities", AAPS PharmSciTech, 24, 102, 2023 - Published online:11 April 2023. (Impact Factor: 4.026). https://link.springer.com/02555-2article/10.1208/s12249-023-
- Sarita Rani, Rakesh Kumar Sahoo, Vinay Kumar, Akash Chaurasiya, Onkar Kulkarni, Ashutosh Mahale, Sumeet Katke, Kaushik Kuche, Vivek Yadav, Sanyog Jain, Kartik Nakhate, Ajazuddin, Umesh Gupta, “N-2-hydroxypropylmethacrylamide–polycaprolactone polymeric micelles in co-delivery of proteasome inhibitor and polyphenol: Exploration of synergism or antagonism”, Molecular Pharmaceutics, 20, 524-544, 2023. (Impact Factor: 5.364).
https://doi.org/10.1021/acs.molpharmaceut.2c00752 - Akash Chaurasiya, Kanan Panchal, Sumeet Katke, Stable Oral Compositions of Posaconazole for Treating Fungal Infections, Indian Patent Authority, Application No. 202211001449, Application Submission Date: Jan 11 2022.
- Kanan Panchal, Sumeet Katke, Sanat Kumar Dash, Ankit Gaur, Aishwarya Shinde, Nithun Saha, Neelesh Kumar Mehra, Akash Chaurasiya, “An expanding horizon of complex injectable products: Development and regulatory considerations”, Drug Delivery & Translational Research, 13, 433-472, 2023. (Scopus indexed; Impact Factor: 5.671). https://doi.org/10.1007/s13346-022-01223-5
- Akash Chaurasiya, Amruta Gorajiya, Kanan Panchal, Sumeet Katke & Ajeet Kumar Singh, “A review on multivesicular liposomes for pharmaceutical applications: Preparation, characterization and translational challenges”, Drug Delivery & Translational Research, 12, 1569-1587, 2022. (Scopus indexed; Impact Factor: 5.671). https://doi.org/10.1007/s13346-021-01060-y
- Aishwarya Shinde, Kanan Panchal, Sumeet Katke, Rishi Paliwal, Akash Chaurasiya, “Tyrosine kinase inhibitors as next generation oncological therapeutics: Current strategies, limitations and future perspective”, Therapies, 77, 425-443, 2022. (Scopus indexed; Impact Factor: 3.367). https://doi.org/10.1016/j.therap.2021.10.010
- Rishi Paliwal, Pramod Kumar, Akash Chaurasiya, Rameshroo Kenwat, Sumeet Katke, Shivani Rai Paliwal, “Development of nanomedicines and nanosimilars: Recent advances in regulatory landscape”, Current Pharmaceutical Design, 28, 165-177, 2022. (Impact Factor: 3.310). https://doi.org/10.2174/1381612827666211115170001
- Akash Chaurasiya, Sumeet Katke, Kanan Panchal & Nirmal Jayabalan “Biologics for the management of dementia”. In Nanomedicine-Based Approaches for the Treatment of Dementia, Elsevier. pp 193-234, 2022. https://doi.org/10.1016/B978-0-12-824331-2.00001-7
- Akash Chaurasiya, Sumeet Katke & Kanan Panchal “Nanotechnology-based approaches for Cancer Therapeutics”. In Nanomedicine, Nanotheranostics and Nanobiotechnology: Fundamentals and Applications, CRC - Taylor and Francis (In press). 2021.
3. Ms. Kanan Panchal
Ph.D. Student (ICMR JRF Fellow)
Research Area: Development of liposomal carrier system for anticancer drug delivery
M. Pharm.: BITS Pilani - Hyderabad Campus
Novartis Bio-Camp 2021 Participant
Publications (TPRL Group):
- Kanan Panchal, Akhila Reddy, Rishi Paliwal, Akash Chaurasiya, "Dynamic intervention to enhance the stability of PEGylated Ibrutinib loaded lipidic nano-vesicular systems: transitioning from colloidal dispersion to lyophilized product"Drug Delivery and Translational Research, in press (Scopus indexed; Impact Factor: 5.4).
- Akash Chaurasiya, Sonali Singh, Kanan Panchal, Rishi Paliwal, Akanksha Malviya “ Fundamentals of targeted drug delivery system”.Molecular pharmaceutics and nano drug delivery: Fundamentals and Challenges, Elsevier. pp 289-309.https://doi.org/10.1016/B978-0-323-91924-1.00007-1
- Rani, Sarita, Sahoo Rakesh Kumar, Mahale Ashutosh, Panchal Kanan, Chaurasiya Akash, Kulkarni Onkar, Kuche Kaushik, Jain Sanyog, Nakhate Kartik Ajazuddin, Gupta Umesh, "Sialic Acid Engineered Prodrug Nanoparticles for Co-delivery of Bortezomib and Selenium in Tumor Bearing Mice" Bioconjugate Chemistry Manuscript ID: bc-2023-00210n.R3
- Akash Chaurasiya, Kanan Panchal, Lipid Based Pharmaceutical Composition of BTK Inhibitor, Indian Patent Authority, Application No. 202211003679, Application Submission Date: Jan 22 2022.
- Akash Chaurasiya, Kanan Panchal, Sumeet Katke, Stable Oral Compositions of Posaconazole for Treating Fungal Infections, Indian Patent Authority, Application No. 202211001449, Application Submission Date: Jan 11 2022.
- Rachna M. Kumar, Hitesh Kumar, Tanvi Bhatt, Rupshee Jain, Kanan Panchal, Akash Chaurasiya, Vikas Jain, “Fisetin in Breast Cancer: Attributes, Developmental Aspects and Nanotherapeutics”, Pharmaceuticals, 16, 196, 2023. (Impact Factor: 5.215). https://doi.org/10.3390/ph16020196
- Kanan Panchal, Sumeet Katke, Sanat Kumar Dash, Ankit Gaur, Aishwarya Shinde, Nithun Saha, Neelesh Kumar Mehra, Akash Chaurasiya, “An expanding horizon of complex injectable products: Development and regulatory considerations”, Drug Delivery & Translational Research, 13, 433-472, 2023. (Scopus indexed; Impact Factor: 5.671). https://doi.org/10.1007/s13346-022-01223-5
- Kanan Panchal, Rakesh Kumar Sahoo, Umesh Gupta, Akash Chaurasiya, Role of Targeted Immunotherapy for Pancreatic Ductal Adenocarcinoma (PDAC) Treatment: An Overview, International Immunopharmacology, 95, 107508, 2021. (Scopus indexed; Impact Factor: 5.714). https://doi.org/10.1016/j.intimp.2021.107508
- Akash Chaurasiya, Amruta Gorajiya, Kanan Panchal, Sumeet Katke & Ajeet Kumar Singh, “A review on multivesicular liposomes for pharmaceutical applications: Preparation, characterization and translational challenges”, Drug Delivery & Translational Research, 12, 1569-1587, 2022. (Scopus indexed; Impact Factor: 5.671). https://doi.org/10.1007/s13346-021-01060-y
- Aishwarya Shinde, Kanan Panchal, Sumeet Katke, Rishi Paliwal, Akash Chaurasiya, “Tyrosine kinase inhibitors as next generation oncological therapeutics: Current strategies, limitations and future perspective”, Therapies, 77, 425-443, 2022. (Scopus indexed; Impact Factor: 3.367). https://doi.org/10.1016/j.therap.2021.10.010
- Akash Chaurasiya, Sumeet Katke, Kanan Panchal & Nirmal Jayabalan “Biologics for the management of dementia”. In Nanomedicine-Based Approaches for the treatment of Dementia, Elsevier. pp 193-234, 2022. https://doi.org/10.1016/B978-0-12-824331-2.00001-7
- Rishi Paliwal, Akash Chaurasiya, Kanan Panchal, Pooja Nayak, Nilosha Parveen & Shivani Rai Paliwal, “Engineering and functionalization of nanomaterials for theranostic applications in infectious diseases”. In Nanotheranostics for Treatment and Diagnosis of Infectious Diseases, Elsevier. pp 45-71, 2022. https://doi.org/10.1016/B978-0-323-91201-3.00003-7
- Akash Chaurasiya, Sumeet Katke & Kanan Panchal, “Nanotechnology-based approaches for Cancer Therapeutics”. In Nanomedicine, Nanotheranostics and Nanobiotechnology: Fundamentals and Applications, CRC - Taylor and Francis (In press), 2021.
4. Ms. Sonali Singh
Ph.D. Student
Research Area: Nanomedicine based approaches for tumor targeting
MS Pharm.: NIPER, Raebareli, UP, India
Project Trainee: CSIR-CDRI, Lucknow, UP, India
Publications (TPRL Group):
- Akash Chaurasiya, Sonali Singh, Kanan Panchal, Rishi Paliwal, Akanksha Malviya “ Fundamentals of targeted drug delivery system”.Molecular pharmaceutics and nano drug delivery: Fundamentals and Challenges, Elsevier. pp 289-309.https://doi.org/10.1016/B978-0-323-91924-1.00007-1
5. Mr. Siddhant Padhi
Ph.D. Student
Research Area: Nanocarrier mediated drug delivery for anticancer drugs
M. Pharm.: Manipal College of Pharmaceutical Sciences, MAHE, Manipal, India
6. Mr. Rahul Bhise
Sr. Manager - Slayback Pharma
Ph.D. Student: Part time under Industrial Collaboration
Research Area: Complex injectables product development
M. Pharm.: Manipal College of Pharmaceutical Sciences, MAHE, Manipal, India
7. Mr. Sushant Dube
Director - Slayback Pharma
Ph.D. Student: Part time under Industrial Collaboration
Research Area: Development and evaluation of oral drug-loaded nanocarrier system for cancer treatment
M. Pharm.: University Department of Pharmaceutical Sciences, Nagpur University, Maharashtra, India
Publications (TPRL Group):
- Sushant Omprakash Dube, Ajay Kumar Singh, Akash Chaurasiya, Chiranjeev Singh, Suprit Dilip Saoji, Pharmaceutical Combinations of Ibrutinib, Patent Application No. IN202041053973, Application Submission Date: Dec 11 2020.